annual SGA:
$14.73B-$41.00M(-0.28%)Summary
- As of today (May 31, 2025), PFE annual SGA is $14.73 billion, with the most recent change of -$41.00 million (-0.28%) on December 31, 2024.
- During the last 3 years, PFE annual SGA has risen by +$2.03 billion (+15.96%).
- PFE annual SGA is now -22.36% below its all-time high of $18.97 billion, reached on December 31, 2010.
Performance
PFE SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$3.03B-$1.24B(-29.08%)Summary
- As of today (May 31, 2025), PFE quarterly SGA is $3.03 billion, with the most recent change of -$1.24 billion (-29.08%) on March 29, 2025.
- Over the past year, PFE quarterly SGA has dropped by -$464.00 million (-13.28%).
- PFE quarterly SGA is now -46.58% below its all-time high of $5.67 billion, reached on December 31, 1998.
Performance
PFE quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$473.97B-$1.73B(-0.36%)Summary
- As of today (May 31, 2025), PFE TTM SGA is $473.97 billion, with the most recent change of -$1.73 billion (-0.36%) on March 29, 2025.
- Over the past year, PFE TTM SGA has increased by +$459.12 billion (+3092.15%).
- PFE TTM SGA is now -7.42% below its all-time high of $511.96 billion.
Performance
PFE TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
PFE Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -0.3% | -13.3% | +3092.2% |
3 y3 years | +16.0% | +16.9% | +3686.0% |
5 y5 years | +15.8% | +19.3% | +3873.6% |
PFE Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -0.3% | +16.0% | -34.8% | +16.9% | -7.4% | +14.7% |
5 y | 5-year | -0.3% | +27.0% | -34.8% | +19.3% | -7.4% | +24.0% |
alltime | all time | -22.4% | +883.8% | -46.6% | +770.6% | -7.4% | >+9999.0% |
PFE Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $3.03B(-29.1%) | $14.27B(-3.2%) |
Dec 2024 | $14.73B(-0.3%) | $4.27B(+31.8%) | $14.73B(-2.0%) |
Sep 2024 | - | $3.24B(-12.7%) | $15.03B(-0.2%) |
Jun 2024 | - | $3.72B(+6.4%) | $15.07B(+1.5%) |
Mar 2024 | - | $3.50B(-23.6%) | $14.85B(+0.5%) |
Dec 2023 | $14.77B(+8.0%) | $4.58B(+39.4%) | $14.77B(-0.5%) |
Sep 2023 | - | $3.28B(-6.2%) | $14.84B(-0.7%) |
Jun 2023 | - | $3.50B(+2.3%) | $14.95B(+3.1%) |
Mar 2023 | - | $3.42B(-26.4%) | $14.50B(+6.0%) |
Dec 2022 | $13.68B(+7.7%) | $4.64B(+37.0%) | $13.68B(+4.1%) |
Sep 2022 | - | $3.39B(+11.3%) | $13.14B(+3.9%) |
Jun 2022 | - | $3.05B(+17.5%) | $12.64B(+1.0%) |
Mar 2022 | - | $2.59B(-36.8%) | $12.52B(-1.4%) |
Dec 2021 | $12.70B(+9.5%) | $4.10B(+41.6%) | $12.70B(+3.0%) |
Sep 2021 | - | $2.90B(-0.8%) | $12.34B(+2.0%) |
Jun 2021 | - | $2.92B(+5.3%) | $12.10B(+2.2%) |
Mar 2021 | - | $2.78B(-25.7%) | $11.83B(+2.0%) |
Dec 2020 | $11.60B(-8.9%) | $3.74B(+40.7%) | $11.60B(+10.7%) |
Sep 2020 | - | $2.66B(-0.0%) | $10.47B(-5.4%) |
Jun 2020 | - | $2.66B(+4.6%) | $11.08B(-7.1%) |
Mar 2020 | - | $2.54B(-2.9%) | $11.93B(-6.3%) |
Dec 2019 | $12.73B(+0.9%) | $2.62B(-19.8%) | $12.73B(+3.7%) |
Sep 2019 | - | $3.26B(-7.1%) | $12.27B(-1.9%) |
Jun 2019 | - | $3.51B(+5.2%) | $12.51B(-0.2%) |
Mar 2019 | - | $3.34B(+54.3%) | $12.54B(-0.6%) |
Dec 2018 | $12.61B(-14.8%) | $2.16B(-38.1%) | $12.61B(-15.9%) |
Sep 2018 | - | $3.49B(-1.4%) | $15.00B(-0.1%) |
Jun 2018 | - | $3.54B(+3.8%) | $15.01B(+0.8%) |
Mar 2018 | - | $3.41B(-25.1%) | $14.90B(+0.7%) |
Dec 2017 | $14.80B(-0.3%) | $4.55B(+30.0%) | $14.80B(+0.9%) |
Sep 2017 | - | $3.50B(+2.2%) | $14.68B(-0.4%) |
Jun 2017 | - | $3.43B(+3.5%) | $14.73B(-0.3%) |
Mar 2017 | - | $3.31B(-25.2%) | $14.78B(-0.5%) |
Dec 2016 | $14.84B(+0.2%) | $4.43B(+24.5%) | $14.85B(-4.0%) |
Sep 2016 | - | $3.56B(+2.5%) | $15.46B(+1.9%) |
Jun 2016 | - | $3.47B(+2.5%) | $15.17B(+0.6%) |
Mar 2016 | - | $3.38B(-32.9%) | $15.09B(+1.9%) |
Dec 2015 | $14.81B(+5.1%) | $5.05B(+54.4%) | $14.81B(+7.8%) |
Sep 2015 | - | $3.27B(-3.4%) | $13.74B(-2.0%) |
Jun 2015 | - | $3.39B(+9.1%) | $14.03B(-0.9%) |
Mar 2015 | - | $3.10B(-22.0%) | $14.16B(+0.5%) |
Dec 2014 | $14.10B(-1.8%) | $3.98B(+12.0%) | $14.10B(-1.2%) |
Sep 2014 | - | $3.56B(+1.0%) | $14.27B(+1.1%) |
Jun 2014 | - | $3.52B(+15.8%) | $14.11B(-0.5%) |
Mar 2014 | - | $3.04B(-26.8%) | $14.18B(-1.2%) |
Dec 2013 | $14.36B(-5.4%) | $4.15B(+22.3%) | $14.36B(-1.3%) |
Sep 2013 | - | $3.40B(-5.5%) | $14.54B(-0.7%) |
Jun 2013 | - | $3.59B(+11.6%) | $14.64B(-0.5%) |
Mar 2013 | - | $3.22B(-25.8%) | $14.71B(-4.9%) |
Dec 2012 | $15.17B(-13.7%) | $4.34B(+24.2%) | $15.46B(+2.6%) |
Sep 2012 | - | $3.49B(-4.7%) | $15.07B(-6.0%) |
Jun 2012 | - | $3.67B(-7.6%) | $16.04B(-6.6%) |
Mar 2012 | - | $3.97B(+0.6%) | $17.17B(-3.0%) |
Dec 2011 | $17.58B(-7.3%) | $3.95B(-11.5%) | $17.71B(-6.6%) |
Sep 2011 | - | $4.46B(-7.1%) | $18.96B(-0.7%) |
Jun 2011 | - | $4.80B(+6.6%) | $19.10B(+0.1%) |
Mar 2011 | - | $4.50B(-13.4%) | $19.07B(+0.5%) |
Dec 2010 | $18.97B(+27.5%) | $5.20B(+13.0%) | $18.97B(-0.9%) |
Sep 2010 | - | $4.60B(-3.7%) | $19.14B(+7.4%) |
Jun 2010 | - | $4.77B(+8.4%) | $17.83B(+8.7%) |
Mar 2010 | - | $4.40B(-18.0%) | $16.40B(+10.3%) |
Dec 2009 | $14.88B(+2.3%) | $5.37B(+63.5%) | $14.88B(+13.0%) |
Sep 2009 | - | $3.28B(-2.0%) | $13.17B(-1.8%) |
Jun 2009 | - | $3.35B(+16.5%) | $13.41B(-3.7%) |
Mar 2009 | - | $2.88B(-21.4%) | $13.92B(-4.2%) |
Dec 2008 | $14.54B(-7.0%) | $3.66B(+3.9%) | $14.54B(-6.4%) |
Sep 2008 | - | $3.52B(-8.8%) | $15.53B(-1.6%) |
Jun 2008 | - | $3.86B(+10.6%) | $15.78B(+0.1%) |
Mar 2008 | - | $3.49B(-25.0%) | $15.76B(+0.8%) |
Dec 2007 | $15.63B(+0.2%) | $4.65B(+23.5%) | $15.63B(+0.6%) |
Sep 2007 | - | $3.77B(-2.0%) | $15.54B(+0.1%) |
Jun 2007 | - | $3.84B(+14.4%) | $15.52B(-0.2%) |
Mar 2007 | - | $3.36B(-26.3%) | $15.55B(-0.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2006 | $15.59B(+1.8%) | $4.56B(+21.6%) | $15.59B(+1.3%) |
Sep 2006 | - | $3.75B(-3.3%) | $15.38B(+1.5%) |
Jun 2006 | - | $3.88B(+14.3%) | $15.16B(+0.8%) |
Mar 2006 | - | $3.40B(-22.0%) | $15.04B(-4.4%) |
Dec 2005 | $15.31B(+0.1%) | $4.36B(+23.5%) | $15.73B(+8.8%) |
Sep 2005 | - | $3.53B(-6.4%) | $14.45B(-3.4%) |
Jun 2005 | - | $3.77B(-7.8%) | $14.96B(-3.2%) |
Mar 2005 | - | $4.08B(+32.8%) | $15.46B(+1.0%) |
Dec 2004 | $15.30B(+1.3%) | $3.08B(-23.8%) | $15.30B(-9.2%) |
Sep 2004 | - | $4.04B(-5.2%) | $16.86B(+0.2%) |
Jun 2004 | - | $4.26B(+8.3%) | $16.81B(+3.2%) |
Mar 2004 | - | $3.93B(-15.0%) | $16.30B(+7.9%) |
Dec 2003 | $15.11B(+39.5%) | $4.63B(+15.9%) | $15.11B(+12.4%) |
Sep 2003 | - | $3.99B(+6.7%) | $13.45B(+11.0%) |
Jun 2003 | - | $3.74B(+36.4%) | $12.11B(+9.8%) |
Mar 2003 | - | $2.74B(-7.5%) | $11.03B(+1.8%) |
Dec 2002 | $10.83B(+11.4%) | $2.96B(+11.6%) | $10.83B(+11.4%) |
Sep 2002 | - | $2.66B(-0.2%) | $9.72B(+0.6%) |
Jun 2002 | - | $2.66B(+4.6%) | $9.66B(-1.5%) |
Mar 2002 | - | $2.54B(+37.1%) | $9.81B(-0.4%) |
Dec 2001 | $9.72B(-13.4%) | $1.86B(-28.5%) | $9.84B(-10.5%) |
Sep 2001 | - | $2.60B(-7.6%) | $11.00B(-0.5%) |
Jun 2001 | - | $2.81B(+8.9%) | $11.06B(-0.1%) |
Mar 2001 | - | $2.58B(-14.5%) | $11.07B(-1.4%) |
Dec 2000 | $11.22B(+3.8%) | $3.02B(+13.8%) | $11.22B(+0.7%) |
Sep 2000 | - | $2.65B(-6.2%) | $11.15B(+0.8%) |
Jun 2000 | - | $2.82B(+3.3%) | $11.07B(+1.5%) |
Mar 2000 | - | $2.73B(-7.1%) | $10.90B(+11.9%) |
Dec 1999 | $10.81B(+13.0%) | $2.94B(+14.7%) | $9.74B(-21.9%) |
Sep 1999 | - | $2.57B(-3.5%) | $12.47B(+11.1%) |
Jun 1999 | - | $2.66B(+69.4%) | $11.23B(+13.0%) |
Mar 1999 | - | $1.57B(-72.3%) | $9.93B(+3.9%) |
Dec 1998 | $9.56B(+117.3%) | $5.67B(+328.9%) | $9.56B(+85.6%) |
Sep 1998 | - | $1.32B(-3.2%) | $5.15B(+5.6%) |
Jun 1998 | - | $1.37B(+14.0%) | $4.88B(+2.6%) |
Mar 1998 | - | $1.20B(-5.1%) | $4.76B(+4.8%) |
Dec 1997 | $4.40B(+14.0%) | $1.26B(+20.2%) | $4.54B(+60.7%) |
Sep 1997 | - | $1.05B(-15.6%) | $2.83B(-12.3%) |
Jun 1997 | - | $1.25B(+26.8%) | $3.22B(-9.1%) |
Mar 1997 | - | $982.00M(-317.3%) | $3.54B(-9.6%) |
Dec 1996 | $3.86B(-27.1%) | -$452.00M(-131.3%) | $3.92B(-33.3%) |
Sep 1996 | - | $1.45B(-7.7%) | $5.88B(+2.3%) |
Jun 1996 | - | $1.57B(+15.1%) | $5.74B(+4.1%) |
Mar 1996 | - | $1.36B(-9.5%) | $5.52B(+2.6%) |
Dec 1995 | $5.30B(+20.7%) | $1.50B(+14.6%) | $5.38B(+4.9%) |
Sep 1995 | - | $1.31B(-2.3%) | $5.13B(+4.5%) |
Jun 1995 | - | $1.34B(+10.0%) | $4.91B(+6.1%) |
Mar 1995 | - | $1.22B(-2.4%) | $4.63B(+5.4%) |
Dec 1994 | $4.39B(-8.4%) | $1.25B(+14.6%) | $4.39B(-12.2%) |
Sep 1994 | - | $1.09B(+2.8%) | $5.00B(+2.1%) |
Jun 1994 | - | $1.06B(+7.8%) | $4.89B(+6.6%) |
Mar 1994 | - | $985.20M(-47.0%) | $4.59B(+0.6%) |
Dec 1993 | $4.79B(+27.4%) | $1.86B(+88.2%) | $4.56B(+21.0%) |
Sep 1993 | - | $987.90M(+30.3%) | $3.77B(+2.3%) |
Jun 1993 | - | $757.90M(-20.7%) | $3.68B(-4.3%) |
Mar 1993 | - | $956.10M(-10.4%) | $3.85B(+2.4%) |
Dec 1992 | $3.76B(+7.6%) | $1.07B(+18.2%) | $3.76B(+2.5%) |
Sep 1992 | - | $903.10M(-2.4%) | $3.67B(+1.3%) |
Jun 1992 | - | $925.40M(+6.8%) | $3.62B(+1.7%) |
Mar 1992 | - | $866.50M(-11.2%) | $3.56B(+2.0%) |
Dec 1991 | $3.50B(+13.0%) | $976.30M(+14.1%) | $3.50B(+1.6%) |
Sep 1991 | - | $855.50M(-1.2%) | $3.44B(+3.4%) |
Jun 1991 | - | $866.30M(+8.6%) | $3.33B(+3.5%) |
Mar 1991 | - | $797.80M(-13.3%) | $3.22B(+4.0%) |
Dec 1990 | $3.09B(+17.1%) | $920.50M(+24.0%) | $3.09B(+42.4%) |
Sep 1990 | - | $742.50M(-1.6%) | $2.17B(+51.9%) |
Jun 1990 | - | $754.30M(+11.7%) | $1.43B(+111.7%) |
Mar 1990 | - | $675.50M | $675.50M |
Dec 1989 | $2.64B(+12.2%) | - | - |
Dec 1988 | $2.35B(+13.0%) | - | - |
Dec 1987 | $2.08B(+15.9%) | - | - |
Dec 1986 | $1.80B(+12.3%) | - | - |
Dec 1985 | $1.60B(+6.8%) | - | - |
Dec 1984 | $1.50B | - | - |
FAQ
- What is Pfizer annual SGA?
- What is the all time high annual SGA for Pfizer?
- What is Pfizer annual SGA year-on-year change?
- What is Pfizer quarterly SGA?
- What is the all time high quarterly SGA for Pfizer?
- What is Pfizer quarterly SGA year-on-year change?
- What is Pfizer TTM SGA?
- What is the all time high TTM SGA for Pfizer?
- What is Pfizer TTM SGA year-on-year change?
What is Pfizer annual SGA?
The current annual SGA of PFE is $14.73B
What is the all time high annual SGA for Pfizer?
Pfizer all-time high annual SGA is $18.97B
What is Pfizer annual SGA year-on-year change?
Over the past year, PFE annual SGA has changed by -$41.00M (-0.28%)
What is Pfizer quarterly SGA?
The current quarterly SGA of PFE is $3.03B
What is the all time high quarterly SGA for Pfizer?
Pfizer all-time high quarterly SGA is $5.67B
What is Pfizer quarterly SGA year-on-year change?
Over the past year, PFE quarterly SGA has changed by -$464.00M (-13.28%)
What is Pfizer TTM SGA?
The current TTM SGA of PFE is $473.97B
What is the all time high TTM SGA for Pfizer?
Pfizer all-time high TTM SGA is $511.96B
What is Pfizer TTM SGA year-on-year change?
Over the past year, PFE TTM SGA has changed by +$459.12B (+3092.15%)